A unicorn built on lies? Founders of Sanofi partner may face 20 years in prison for allegedly profiting from stolen Genentech trade secrets
Just how much are Genentech trade secrets worth?
The storied South San Francisco biotech and Roche subsidiary unearthed a covert operation to profit from years of experience and knowhow when it accused Taiwan’s JHL Biotech of stealing information through one of its senior scientists. JHL, which had scored a pact with Sanofi to market biosimilars of Genentech’s top-selling drugs, has since settled the case and agreed to shut down any related work.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 112,900+ biopharma pros reading Endpoints daily — and it's free.